Rebecca J. Brownlie
Leeds Institute Of Medical Research At St. James's, St. James's University Hospital
Leeds, ENG, United Kingdom
Leeds, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Phospho-enol pyruvate carboxykinase inhibition limits effector function in inflammatory T cells.
Journal: Frontiers in immunology
Published: September 15, 2025
Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma.
Journal: International journal of cancer
Published: January 28, 2025
Natural killer cells are required for the recruitment of CD8+ T cells and the efficacy of immune checkpoint blockade in melanoma brain metastases.
Journal: Journal for immunotherapy of cancer
Published: October 26, 2024
Regulation of T Cell Signaling and Immune Responses by PTPN22.
Journal: Molecular and cellular biology
Published: July 23, 2024
OT-I TCR Transgenic Mice to Study the Role of PTPN22 in Anti-cancer Immunity.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 26, 2023
Deletion of the protein tyrosine phosphatase PTPN22 for adoptive T cell therapy facilitates CTL effector function but promotes T cell exhaustion.
Journal: Journal for immunotherapy of cancer
Published: November 01, 2023
B cells ferment sugar before they (affinity) mature.
Journal: Nature immunology
Published: June 26, 2023
Cytokine receptor IL27RA is an NF-κB-responsive gene involved in CD38 upregulation in multiple myeloma.
Journal: Blood advances
Published: September 29, 2022
Hematopoietic stem cell gene therapy targeting TGFβ enhances the efficacy of irradiation therapy in a preclinical glioblastoma model.
Journal: Journal for immunotherapy of cancer
Published: January 12, 2021
Deletion of PTPN22 improves effector and memory CD8+ T cell responses to tumors.
Journal: JCI insight
Published: July 24, 2019
Hematopoietic Stem Cell Gene Therapy for Brain Metastases Using Myeloid Cell-Specific Gene Promoters.
Journal: Journal of the National Cancer Institute
Published: September 17, 2018
Last Updated: 09/26/2026